Follow
Vladimir Gushchin, PhD
Vladimir Gushchin, PhD
Head of laboratory in Gamaleya Research Center of Epidemiology and Microbiology
Verified email at gamaleya.org
Title
Cited by
Cited by
Year
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
DY Logunov, IV Dolzhikova, DV Shcheblyakov, AI Tukhvatulin, ...
The Lancet 397 (10275), 671-681, 2021
20192021
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
E Alm, EK Broberg, T Connor, EB Hodcroft, AB Komissarov, ...
Eurosurveillance 25 (32), 2001410, 2020
2562020
Neutralizing activity of sera from Sputnik V-vaccinated people against variants of concern (VOC: B. 1.1. 7, B. 1.351, P. 1, B. 1.617. 2, B. 1.617. 3) and Moscow endemic SARS …
VA Gushchin, IV Dolzhikova, AM Shchetinin, AS Odintsova, AE Siniavin, ...
Vaccines 9 (7), 779, 2021
1252021
Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation
M Khaitov, A Nikonova, I Shilovskiy, K Kozhikhova, I Kofiadi, ...
Allergy 76 (9), 2840-2854, 2021
912021
Non-labeled selective virus detection with novel SERS-active porous silver nanofilms fabricated by Electron Beam Physical Vapor Deposition
NN Durmanov, RR Guliev, AV Eremenko, IA Boginskaya, IA Ryzhikov, ...
Sensors and Actuators B: Chemical 257, 37-47, 2018
872018
Gam-COVID-Vac Vaccine Trial Group Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised …
DY Logunov, IV Dolzhikova, DV Shcheblyakov, AI Tukhvatulin, ...
Lancet 397 (10275), 671-681, 2021
852021
Broad Bactericidal Activity of the Myoviridae Bacteriophage Lysins LysAm24, LysECD7, and LysSi3 against Gram-Negative ESKAPE Pathogens
NP Antonova, DV Vasina, AM Lendel, EV Usachev, VV Makarov, ...
Viruses 11 (3), 284, 2019
742019
SERS-based aptasensor for rapid quantitative detection of SARS-CoV-2
E Zavyalova, O Ambartsumyan, G Zhdanov, D Gribanyov, V Gushchin, ...
Nanomaterials 11 (6), 1394, 2021
672021
An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in …
AI Tukhvatulin, IV Dolzhikova, DV Shcheblyakov, OV Zubkova, ...
The Lancet Regional Health–Europe 11, 2021
652021
Isolation and characterisation of Alongshan virus in Russia
IS Kholodilov, AG Litov, AS Klimentov, OA Belova, AE Polienko, NA Nikitin, ...
Viruses 12 (4), 362, 2020
572020
Multi-subunit BCG booster vaccine GamTBvac: Assessment of immunogenicity and protective efficacy in murine and guinea pig TB models
AP Tkachuk, VA Gushchin, VD Potapov, AV Demidenko, VG Lunin, ...
PloS one 12 (4), e0176784, 2017
562017
First-in-human trials of GamTBvac, a recombinant subunit tuberculosis vaccine candidate: safety and immunogenicity assessment
DV Vasina, DA Kleymenov, VA Manuylov, EP Mazunina, EY Koptev, ...
Vaccines 7 (4), 166, 2019
382019
Geographical and tick-dependent distribution of flavi-like Alongshan and Yanggou tick viruses in Russia
IS Kholodilov, OA Belova, ES Morozkin, AG Litov, AY Ivannikova, ...
Viruses 13 (3), 458, 2021
362021
Modulation of endolysin LysECD7 bactericidal activity by different peptide tag fusion
NP Antonova, DV Vasina, EO Rubalsky, MV Fursov, AS Savinova, ...
Biomolecules 10 (3), 440, 2020
352020
Snake venom phospholipase A2s exhibit strong virucidal activity against SARS-CoV-2 and inhibit the viral spike glycoprotein interaction with ACE2
AE Siniavin, MA Streltsova, MA Nikiforova, DS Kudryavtsev, SD Grinkina, ...
Cellular and Molecular Life Sciences 78 (23), 7777-7794, 2021
342021
Resistance to peptidoglycan-degrading enzymes
AV Grishin, AS Karyagina, DV Vasina, IV Vasina, VA Gushchin, VG Lunin
Critical Reviews in Microbiology 46 (6), 703-726, 2020
342020
Safety and immunogenicity of the GamTBvac, the recombinant subunit tuberculosis vaccine candidate: a phase II, multi-center, double-blind, randomized, placebo-controlled study
AP Tkachuk, EN Bykonia, LI Popova, DA Kleymenov, MA Semashko, ...
Vaccines 8 (4), 652, 2020
332020
Antibiofilm activity of a broad-range recombinant endolysin LysECD7: in vitro and in vivo study
MV Fursov, RO Abdrakhmanova, NP Antonova, DV Vasina, ...
Viruses 12 (5), 545, 2020
302020
The rise and spread of the SARS-CoV-2 AY. 122 lineage in Russia
GV Klink, KR Safina, E Nabieva, N Shvyrev, S Garushyants, E Alekseeva, ...
Virus Evolution 8 (1), veac017, 2022
282022
Guide RNA design for CRISPR/Cas9-mediated potato genome editing
AV Khromov, VA Gushchin, VI Timerbaev, NO Kalinina, ME Taliansky, ...
Doklady Biochemistry and Biophysics 479 (1), 90-94, 2018
282018
The system can't perform the operation now. Try again later.
Articles 1–20